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ABSTRACT
Coronary stent implantation can improve blood flow in an
artery narrowed by the build up of arterial plaque. However,
the haemodynamic effect of stent placement is unclear and
may influence arterial restenosis (re-blockage). In this
investigation computational fluid dynamics (CFD) was used
to predict the non-Newtonian three-dimensional flow field in
a coronary artery following implantation of two different
stents. A graphical illustration of the stented areas affected to
various degrees of wall shear stress (WSS) is presented for
both the Palmaz-Schatz (PS) and the Gianturco-Roubin-II
(GR-II) coronary stents. The axial WSS and wall shear stress
gradient (WSSG) is also presented graphically over one stent
strut for each stent. Finally, a comparison is drawn between
the CFD results and restenosis data from a clinical trial.
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1. Introduction
Coronary artery disease (CAD) is one of the leading causes
of death in the developed world. CAD occurs due to the
build up of plaque in the coronary arteries which supply
fresh blood to the constantly active heart muscle. This build
up of plaque, a condition known as atherosclerosis, deprives
the heart muscle of its crucial supply of oxygen and nutrients
provided by the coronary blood supply. In the past a
coronary artery bypass graft was the only treatment available
for CAD. This is a large scale operation involving the
sawing open of the breastbone and grafting of a blood vessel
to bypass the site of the blockage.
Percutaneous transluminal coronary angioplasty (PTCA)
was introduced in the late 1970s as a minimally invasive
procedure to relieve the narrowing in a coronary artery due
to the build up of plaque. PTCA is accomplished with a
small balloon catheter inserted into an artery in the groin or
arm, and advanced to the narrowing in the coronary artery.
The balloon is then inflated to enlarge the narrowing in the
artery and restore blood flow to the heart muscle. However
in over 40% of patients treated with PTCA the artery
becomes re-blocked within six months in a process known as

restenosis [1]. This is largely due to elastic recoil of the
vessel wall [2].
In the early 1990s stents were introduced to improve the
success rates of PTCA. Basically, a stent is an expandable,
slotted metal tube inserted into the artery. It acts as a
scaffold to provide support for the artery and has proven
effective at eliminating elastic recoil, one mechanism of
restenosis that can result in re-blockage [2]. The use of stents
has shown more promising clinical outcomes than PTCA
alone. However, restenosis remains a persistent problem
with restenosis rates generally as high as 20% at six months
after intervention [3].
The changes in WSS induced by an implanted stent play a
significant role in the immunological behaviour of the
coronary artery. This behaviour is directly linked to
restenosis within the stented artery [4, 5]. In order to assess
the haemodynamic impact of coronary stent implantation,
three-dimensional computational models of a stented left
anterior descending (LAD) coronary artery have been
created using computer-aided-design. One model represents
the artery implanted with a PS stent and the second model
represents the artery implanted with a GR-II stent. CFD was
used to simulate the flow field of the coronary artery with
the implanted stent in each case.
Results are shown of the mesh convergence studies
conducted. Contour plots and graphs of areas of high and
low WSS and a graph of the axial WSSG in the vicinity of
struts for both stents are also presented. The GR-II stent has
been shown to perform poorly against the PS stent in a
recent medical trial. The CFD results presented suggest that
this poor performance is a direct result of the stent induced
haemodynamic factors.

2. Stents
2.1 Introduction
Stents are small tubular prostheses that serve the purpose of
maintaining an adequate inner diameter of a narrowed blood
vessel to allow for the comfortable passage of the blood. In
1986 Jacques Puel and Ulrich Sigwart implanted the first
coronary wallstents in Toulouse, France. Today over 1
million stents are implanted worldwide each year. A stent is

mounted on a balloon-tipped catheter, threaded through the
artery, and positioned at the site of the blockage. As shown
in Figure 1 the balloon is then inflated, opening the stent.
Subsequently, the catheter and deflated balloon are removed,
leaving the stent lodged in place against the inner lining of
the artery.

determine the degree of restenosis that will occur are the
blood clotting platelets which flow through the artery lumen
and the endothelial cells (EC) which form the lunica intima.
Platelets flowing in the artery lumen will bind together to
form a blood clot if they become activated. Platelets can be
activated through contact with a number of different
substances such as thrombin or platelet derived growth
factor (PDGF). Activated platelets will themselves release
these substances to activate platelets around them. However,
PDGF also has the effect of triggering NH. It has been
documented that the platelet deposition near the stent in the
first twelve hours after stenting is a major indicator of the
amount of NH that will occur [6].

Figure 1: The stenting procedure for a narrowed artery.

2.2 Stent Design
The two stent designs modelled using CFD are shown in
Figures 2 and 3 below. The first is the PS coronary stent
manufactured by Johnson and Johnson. The stent is 15 mm
long, consisting of two 7 mm sections joined by a 1 mm
bridge. It ranges from 3 mm to 4 mm in diameter and is a
slotted tube balloon expandable design. The second type of
stent is the GR-II which is manufactured by Cook. The GRII stent has a balloon expandable coil design and is produced
in 20 mm and 40 mm lengths ranging from 2.5 mm to 4 mm
in diameter.

Figure 2: The Palmaz-Schatz coronary stent developed by Johnson and
Johnson.

Figure 3: The Gianturco-Roubin II coronary stent developed by Cook.

2.3 Mechanism of Stent Restenosis
The implantation of a coronary stent leads to vascular injury
and haemodynamic effects which may result in restenosis.
Under normal healthy conditions vascular smooth muscle
cells (VSMC) reside in the lunica media which is shown in
the arterial cross section in Figure 4. Stent restenosis occurs
when VSMC migrate through the lunica intima which is the
inner lining of the artery wall, and build up in the artery
lumen restricting the blood flow, a process known as
neointimal hyperplasia (NH). The main components that

Figure 4: Cross section of a coronary artery.

Platelets and endothelial cells are directly affected by the
shear force exerted by the flowing blood on the artery lumen
wall known as WSS. It has been shown in a two-dimensional
CFD study that areas of low velocity flow and low WSS
exist in the vicinity of newly implanted stent wires [7]. The
platelet deposition and residence times are much higher in
these stagnation areas. This leads to platelet accumulation in
the area around the stent wire leading to increased NH
formation. The stent induced changes in the haemodynamics
of the coronary flow also lead to an alteration of the WSS
exerted on the EC [5, 8]. WSS has been shown to have a
significant effect on the behaviour of EC [9]. A healthy
value for WSS in a coronary artery is approximately 1.5
Pascals [10]. When EC are subjected to values of WSS
lower than this they begin to release adenosine diphosphate
and triphosphate which induces platelet activation leading to
blood clotting and NH formation [9]. Conversely, when
endothelial cells are subjected to areas of "healthy" WSS
they secrete nitrous oxide (NO) which inhibits adhesion of
platelets to the vessel wall and VSMC growth, hence
inhibiting NH formation [10]. Numerous studies have shown
a link between areas of low WSS and increased NH [4, 5].
The success of a stenting procedure relies heavily on the
reendothelialisation of the vessel wall after implantation and
the successful function of the newly formed endothelial cells
to inhibit platelet deposition. If a new layer of EC
successfully grows over the stent the NH formation will
cease. In a study to demonstrate the effect of wall shear
stress gradients (WSSG), EC were exposed to a region of

separated flow. After 48 hours the major finding was that in
the area of the highest WSSG the EC density was up to 40%
less than experimental controls [11]. Through the inhibition
of reendothelialisation, high WSSG contribute to NH
formation [5].
EC will be damaged by the stenting procedure leading to the
release of platelet activating substances and NH formation.
A relationship has been established between vascular injury
and NH [12].
Areas of low WSS, areas of high WSSG, and vascular injury
at the time of stent implantation are the main contributors to
NH formation. In light of this, disturbances to the coronary
blood flow and the degree of trauma to the vessel wall due to
stent implantation cannot be overlooked in future stent
design.

3. CFD Analysis
3.1 Introduction
CFD is a process whereby real-life fluid flows are simulated
using numerical methods to solve the governing equations of
fluid dynamics. CFD is a relatively new branch of fluid
dynamics commonly regarded as the "third" technique for
solution of fluid flow problems, complementing, but not
replacing the well-established approaches of theory and
experiment. CFD finds it niche in modelling fluid flows that
are difficult or impossible to model using theory and are
complex, time consuming or expensive to measure
experimentally.
3.2 The Computational Model
In both computational models a cylindrical domain was
created and the stent design cut from the domain to simulate
conditions of the stent semi-embedded in the artery wall.
One of the 7 mm sections of the PS stent was modelled and a
half section of the 20 mm long GR-II stent was modelled.
The domain extended 2.5 mm proximal (upstream) and 2.5
mm distal (downstream) of the stent in each case to capture
the flow field in those regions.

3.3 Governing Equations of Fluid Mechanics
Both simulations involved steady laminar flow which
requires the CFD code to solve the conservation of mass and
momentum equations, of which the general form are listed as
Equations (1) and (2) respectively:

∂ρ
+ ∇. ρV = 0
∂t

( )

(1)

∂ρV
+ ∇. ρV ⊗ V = −∇p + ∇. (τ ) + ρ g + F (2)
∂t

(

)

where ρ is the fluid density, p is the static pressure, V is the
velocity vector, F represents external body forces such as
gravity, µ is the fluid dynamic viscosity and τ is the shear
stress tensor given by Equation (3):

(

τ = µ ∇V + ∇V

T

)

(3)

At low shear rates blood exhibits the non-Newtonian
behaviour of variable dynamic viscosity which is dependant
on the shear rate. The non-Newtonian nature of the flow is
accommodated by using the Carreau model [13] given in
Equation (4):
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where γ is the rate of deformation tensor given by Equation
(5) for a three-dimensional Cartesian coordinate system
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and the constants for the Carreau model given below have
been established from experimental data [13]:

µ0 = 0.056 Pa.s λ = 3.31 s
µ∞ = 0.00345 Pa.s q = 0.375

(6)

The highly sophisticated commercial software code CFXTM
was used to solve the governing equations of fluid
mechanics for non-Newtonian blood flow in the
computational domain using a vertex-centred finite volume
scheme.

Figure 5: Computational domain representing the left anterior
descending coronary artery with implanted PS stent.

3.4 Boundary Conditions
The same boundary conditions were applied at the inlet,
outlet and on the walls for both simulations.

3.4.1 Inlet Boundary
A fully developed axial velocity profile was applied at the
inlets given by:
V = VMax 1 −

r2
R2

(7)

increase in nodes would lead to no appreciable difference in
the solution. Mesh convergence was achieved for both
simulations by sequentially increasing the number of nodes
until there was no appreciable difference in the axial
distribution of WSS across one of the stent struts between
the solutions.

where the variable r is the radius measured from the
centreline at any point on the inlet plane and R is the radius
at the wall of the domain. VMax is the maximum centreline
velocity given a value of 0.412 m/s in Equation (7) to
simulate resting conditions in the LAD coronary artery [14].

3.4.2 Outlet Boundary
A static pressure of zero Pascals was applied at the outlets of
the both domains, allowing the software to calculate the
velocity at these planes.

3.5 Computational Mesh
Analytical solutions to the governing equations of fluid
mechanics exist for only the simplest of flows under ideal
conditions. To obtain solutions for real flows a numerical
approach must be adopted whereby the equations are
replaced by algebraic approximations which may be solved
using a numerical method. To achieve this, the
computational domain must be divided into a set of much
smaller non-overlapping sub-domains called elements which
constitute the mesh. To obtain an accurate solution a
sufficient number of elements must be placed in the
computational domain. Figure 6 shows the fine mesh
employed in the area around the PS stent wires.

Figure 7: PS Stent strut and sample line upon which mesh convergence
study was carried out.
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3.4.3 Wall Boundary
The no-slip boundary condition was applied on all surfaces
representative of the artery wall and the stent wires.
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Figure 8: Axial distributions of WSS across a PS stent strut as
calculated by successively refined computational meshes.
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Figure 6: Computational mesh in the vicinity of a PS stent strut.

4. Results
4.1 Mesh Convergence Study
A mesh convergence study was carried out to establish the
required mesh density for accurate solutions, such that any
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Figure 9: Axial distributions of WSS across a GR-II stent strut as
calculated by successively refined computational meshes.

4.2 Wall Shear Stress Results
The predicted three-dimensional flow field reveals areas of
high WSS on the tops of the stent struts and low WSS
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Figures 13 and 14 show the axial distribution of WSS and
WSSG over one stent strut transversal to the flow direction
which is where the maximum WSSG appears as shown in
Figures 10 and 11. The magnitude of low WSS on both sides
of the strut is similar for both stents. However, the GR-II
stent displays 15% higher WSS on the top of the stent strut
than the PS stent leading to a 21% higher WSSG in front of
the stent strut and a 44% increase in WSSG behind the strut.

Wall Shear Stress (Pa)

immediately proximal and distal to the stent struts,
particularly those transversal to the blood flow as shown in
Figures 10 and 11. Figure 12 illustrates the percentage
stented area subjected to WSS below a given magnitude
starting from 0.1 Pascals. In comparison to the PS stent, the
GR-II stent has more than double the percentage stented area
subjected to WSS less than 0.1 and 0.25 Pascals, and 70%
more percentage stented area subjected to less than 0.5
Pascals. The GR-II stent also has areas on the stent wires
with higher WSS than the PS stent with a maximum WSS
value of 4.28 Pascals compared to the PS stent which has a
maximum of 3.73 Pascals.
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Figure 10: Contour map of WSS in the vicinity of the implanted PS
coronary stent.
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Figure 13: Distribution of WSS and WSSG in the axial direction over
one of the PS stent struts.
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Figure 11: Contour map of WSS in the vicinity of implanted GR-II
coronary stent.

Figure 14: Distribution of WSS and WSSG in the axial direction over
one of the GR-II stent struts.
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Figure 12: Bar chart illustrating percentage stented area subjected to
varying degrees of WSS for the GR-II and PS stent

It is clear that haemodynamics of the flow in an artery
implanted with a stent have an effect on the immunological
response within the vessel wall of that artery. This work has
demonstrated that stent design has an effect on those
haemodynamic characteristics.
In a medical trial conducted to compare the in vivo
performance of these two stents, the GR-II stent had a
restenosis rate of 47.3% compared to the PS restenosis rate
of 20.6% after six months [15]. Areas of low WSS and high
WSSG have earlier been identified as factors which
encourage the development of NH which leads to restenosis.
The CFD results predict that implantation of the GR-II stent

rather than the PS stent would produce 70% more percentage
stented area subjected to WSS below a value of 0.5 Pa.
Implantation of a GR-II stent would also lead to up to 44%
more WSSG around the stent struts. The medical trial data
and predicted CFD results correlate strongly with the
hypothesis that coronary haemodynamics due to stent design
are a significant factor in whether or not the stenting
procedure will be successful. In light of this evidence, future
stent designs should strive to reduce restenosis encouraging
haemodynamic effects, primarily regions of low WSS and
high WSSG.
This work has demonstrated the ability of applied computer
science to provide the biomedical community with insights
into complex haemodynamics that can be used to assist in
the development of optimal stent designs for the future.
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